Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Alopecia areata treatment varies, with no optimal method established yet.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Stress might contribute to hair loss in alopecia areata.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PRP more effective than minoxidil 5% for treating alopecia areata.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

New genetic discoveries may lead to better treatments for alopecia areata.